Go to deals
Healthcare

MedAxiom has been acquired by American College of Cardiology

The private shareholders of MedAxiom have sold the company to American College of Cardiology, Inc.

MedAxiom was founded in 2001 and is the nation’s leading cardiovascular performance community serving physician practices by providing expert consulting, networking and membership services including data analytics, program excellence tools and educational events to improve business and patient care outcomes.

American College of Cardiology is a trade association that caters to cardiovascular professionals to learn, grow and share knowledge about cardiovascular care and heart health. It also reviews and offers certification courses focusing on cardiovascular diseases. The association helps in the formation of cardiology guidelines, clinical data standards and health policies. Additionally, it publishes cardiovascular journals which focus on cardiovascular diseases, including original clinical studies, translational investigations with clear clinical relevance, state-of-the-art papers, review articles, and editorials interpreting and commenting on the research presented. American College of Cardiology was founded in 1949 and is based in Washington, DC.

Oaklins’ teams in Jacksonville and Savannah acted as financial advisors to MedAxiom in this transaction.

Service
M&A sell-side
Parties
“We are very pleased with the transaction in all respects. We never could have crossed the finish line without the Oaklins team advising us on tough issues, rolling up their sleeves to keep the deal moving and managing the transaction process.”

Jennifer Linville

Founding CEO, MedAxiom

Talk to the deal team

 Daren B. Pietsch

Daren B. Pietsch

Principal

Savannah, United States
Oaklins Heritage
 Doug  Kravet

Doug Kravet

Principal

Jacksonville, United States
Oaklins Heritage
 Howard C. Serkin

Howard C. Serkin

Principal

Jacksonville, United States
Oaklins Heritage

Related deals

Pridiktiv has been acquired by Corilus
Healthcare | TMT

Pridiktiv has been acquired by Corilus

The shareholders and founders of Pridiktiv NV have sold the company to Corilus.

Learn more
Global Media Santé has been acquired by SFP Expansion
Private Equity | Healthcare | TMT

Global Media Santé has been acquired by SFP Expansion

Global Media Santé’s CEO, Alain Trébucq, and Apax Partners have sold the company to SFP Expansion Group.

Learn more
Synairgen has successfully raised US$114 million to support phase III trial of COVID candidate
Healthcare

Synairgen has successfully raised US$114 million to support phase III trial of COVID candidate

Synairgen plc has completed its oversubscribed equity fundraising to raise US$114 million to fund a Phase III trial for 900 patients for the effects of its SNG001 drug on patients with COVID-19. In addition the raise will be used to scale up manufacturing and device activities.

Learn more